The Burden of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Systematic Literature Review (SLR)

被引:6
|
作者
Lenz, Georg [1 ]
Rutherford, Sarah C. [2 ]
Davies, Andrew [3 ]
Zinzani, Pier Luigi [4 ]
Salles, Gilles [5 ]
Hasskarl, Jens [6 ]
Margunato-Debay, Sandra [7 ]
Rodrigues, Filipe [6 ]
Nientker, Lisette [8 ]
Balradj, Janita [8 ]
Alleman, Cathelijne [8 ]
机构
[1] Univ Hosp Munster, Munster, Germany
[2] Weill Cornell Med, Div Hematol & Oncol, New York, NY USA
[3] Univ Southampton, Canc Res UK Ctr, Southampton, Hants, England
[4] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy
[5] CHU Lyon, Lyon, France
[6] Celgene Corp, Boudry, Switzerland
[7] Celgene Corp, Summit, NJ USA
[8] Pharmerit Int, Rotterdam, Netherlands
关键词
D O I
10.1182/blood-2018-99-112878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2241
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Efficacy, Safety, and Patient-Reported Outcomes (PROs) of Treatments for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A Systematic Literature Review (SLR)
    Ma, Qiufei
    Xu, Yingxin
    Srivastava, Rajni
    Kaushik, Namita
    Kaur, Mandeep
    Meng, Yang
    Quek, Ruben G. W.
    Mohamed, Hesham
    Ambati, Srikanth
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S396 - S396
  • [2] Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Gatwood, Justin
    Masaquel, Anthony
    Ross, Ryan
    Sheinson, Danny
    Hossain, Farah
    Li, Jia
    James, Cameron
    Fox, David
    [J]. BLOOD, 2022, 140 : 7906 - 7907
  • [3] Systematic Literature Review of the Clinical Evidence in Relapsed/Refractory (R/R) Large B-Cell Lymphoma
    Maloney, David G.
    Liu, Fei Fei
    Nientker, Lisette
    Alleman, Cathelijne
    Hutton, Brian
    Garcia, Jacob
    [J]. BLOOD, 2019, 134
  • [4] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Dyer, Martin J. S.
    De Vos, Sven
    Ruan, Jia
    Flowers, Christopher
    Maddocks, Kami J.
    Rule, Simon
    Hamdy, Ahmed M.
    Izumi, Raquel
    Slatter, J. Greg
    Cheung, Jean
    Frigualt, Melanie M.
    Wei, Helen
    Mourya, Sanchita
    Hunder, Naomi N. H.
    Fowler, Nathan Hale
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] HUMANISTIC BURDEN IN RELAPSED OR REFRACTORY (R/ R) FOLLICULAR LYMPHOMA (FL): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Forbes, C.
    Pustulka, I
    Nunez-Gonzalez, S.
    Kumar, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S451 - S452
  • [6] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Bell, Jill A.
    Cherepanov, Dasha
    Revicki, Dennis
    Speck, Rebecca M.
    Swett, Laura
    Stumpo, Kate
    Rong, Yuanxin
    Gordon, Leo I.
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
  • [7] Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
    Vukcevic, Mirko
    Yung, Mallory
    Khan, Mali
    Houpt, Bethany
    Schnell, Frederick
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S376 - S377
  • [8] Patient, caregiver, and physician preferences for treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
    Vukcevic, Mirko
    Yung, Mallory
    Khan, Maliha
    Schnell, Frederick Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18710 - E18710
  • [9] Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective
    Moertl, Bernhard
    Dreyling, Martin
    Schmidtl, Christian
    Hoster, Eva
    Schoel, Wolfgang
    V. Bergwelt-Baildon, Michael
    Berger, Karin
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : 474 - 482
  • [10] Economic burden of relapsed/refractory diffuse large B-cell non-Hodgkin's lymphoma (DLBCL): A review of the literature
    Slawsky, K. A.
    Goss, T. F.
    Shinkle, R.
    Xu, X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)